Lytix Biopharma: Interview with CEO Øystein Rekdal

Research Interview

2024-08-15

07:15

Redeye interviews Lytix Biopharma's CEO, Øystein Rekdal, about the positive phase II readout in basal cell carcinoma.

Richard Ramanius

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.